Category Archives: Prescription Drug Claims

Neurologists Urge Caution With Opioids For Non-Cancer Use

The Los Angeles Times reports that patients on opioid painkillers for chronic pain unrelated to cancer, such as headaches, may face a situation where the risks of taking the medications outweigh the benefits. The paper notes that patients “are more likely to risk overdose, addiction and a range of debilitating side effects than they are to improve […]

Boxed Warnings on Antidepressants Tied to Increased Suicide Attempts in Young People

Here’s a case of unintended consequences — warning people that antidepressants might lead to suicide apparently causes the users to actually go ahead and commit suicide. USA Today reports that according to a study published online in the BMJ, boxed “warnings that antidepressant medications might prompt suicidal thinking in some young people may have backfired, resulting in more suicide […]

Warning Labels, Patent Loss Have Greatly Reduced Lawsuits Over Antidepressants

The number of lawsuits over violent acts committed under the influence of antidepressants, which “caused such angst for companies such as Eli Lilly and Co.,” have “pretty much subsided,” reports the Indianapolis Star. While use of the drugs “is as widespread as ever,” the number of suits has fallen off because of the FDA’s decision 10 […]

National Prescription Drug Take Back Day is September 27

The Drug Enforcement Agency is sponsoring a National Prescription Drug Take Back Day, scheduled for September 27, 2014, from 10:00 a.m. to 2:00 p.m. On that day you can take medications to various locations for safe disposal. This is much better than throwing pills in the trash or flushing them down the toilet. Please visit this […]

Drug Makers Paid to Attend Meetings of FDA Advisory Panel

The Washington Post reported that major pharmaceutical companies funded a “scientific panel that shaped the federal government’s policy for testing the safety and effectiveness of painkillers.” The drug makers “paid hundreds of thousands of dollars for the chance to affect the thinking of the Food and Drug Administration, according to hundreds of e-mails obtained by a public […]

Government Experts Highlight Growing Problem of Prescription Painkiller Abuse

The Congressional Quarterly reported “government experts” highlighted the problem of prescription painkiller and heroin abuse as Republicans and Democrats sought advice on how to tackle the growing problem. The article noted that Michael Botticelli, acting director of the Office of National Drug Control Policy, told the House Energy and Commerce Oversight and Investigations Subcommittee that “an average […]

Personal Injuries: When to Settle and When to Fight

If you are hurt in a car accident, during a slip and fall at the grocery store, or while on someone’s property, you may need to file a personal injury lawsuit. It may be difficult to determine when you should fight the case as opposed to settling. Here’s some guidelines to help you make the […]

Generic Drug Maker Ranbaxy Agrees to $500 Million Settlement

On the front of its Business Day section, the New York Times reports that “the generic drug maker Ranbaxy pleaded guilty…to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold subpar drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories […]

States Increasingly Filing Suit Over Drug Marketing Practices

The Wall Street Journal reports that the attorneys general of several states are aggressively pursuing cases based on allegations of deceptive marketing against pharmaceutical giants such as Bristol-Myers Squibb, GlaxoSmithKline and Sanofi SA. For example, in February, the AGs in Kentucky and Maryland filed lawsuits against GSK in their state courts, alleging the company deceptively marketed the […]

Drugmaker Settles Allegations That It Paid Doctors To Prescribe Outdated Antidepressants

Wouldn’t this be terrible? You’re already suffering from depression, and then your doctor gives you an outdated, ineffective medication. You’d end up doubly depressed. This is just shameful behavior. The AP reports that the US attorney’s office in San Francisco announced that the St. Louis-based drugmaker Mallinckrodt “will pay $3.5 million to settle allegations that it paid […]

Pills Tracked From Doctor to Patient to Aid Drug Marketing

This is just wrong — drug companies are apparently keeping records on each of us to find out what medications we’re taking and which doctors are prescribing those medications. The implication is that if the doctor doesn’t prescribe enough medicine for us the drug makers may have a talk with the doctor. This situation was […]

F.D.A. Bars Generic OxyContin

In a major policy move, the Food and Drug Administration has decided that it will not approve generic versions of the powerful, and frequently addictive, narcotic OxyContin, the painkiller that symbolized a decade-long epidemic of prescription drug abuse. This decision will probably result in higher prices for the original medication, and represents a victory for […]

Rate of Pharmaceutical Drug Abuse Grew Significantly in Recent Years

The AP reports, “The rate of pharmaceutical drug abuse has grown significantly in recent years, police say. In fact, more Americans abuse prescription drugs than cocaine, heroin, hallucinogens, Ecstasy and inhalants combined, according to the National Association of Drug Diversion Investigators.” In short, “teens swipe painkillers from a relative’s medicine chest; home health workers pocket pills when […]

Appeals Court Says Neurontin (Gabapentin) Claims Against Pfizer Denied Improperly

Bloomberg News reports Pfizer and its Warner-Lambert unit “may have to face insurers’ lawsuits alleging” they marketed the epilepsy treatment “Neurontin [gabapentin]” for uses not approved by the Food and Drug Administration. A “US Court of Appeals in Boston” ruled yesterday that a “lower-court judge erred in refusing to allow so-called ‘third-party payers,’ such as health […]

“60 Minutes” Investigates Compounding Pharmacies

The CBS Evening News has been airing clips from the “60 Minutes” probe into specialty pharmacies, including the New England Compounding Center, which was linked to the meningitis outbreak last fall. Below is a compilation of the CBS segments as well as video clips of the interviews on “60 Minutes,” including one of FDA Commissioner Dr. Margaret […]

Public Citizen Opposes FDA Proposals for Compounding Labs

The Tennessean says Public Citizen sent HHS Secretary Kathleen Sebelius a letter expressing “strong opposition” to and “great concern” with FDA Commissioner Dr. Margaret Hamburg’s proposals for improved oversight of compounding labs in the wake of the fungal meningitis outbreak. In the letter, the consumer advocate said, “Dr. Hamburg’s performance in the wake of the preventable fungal […]

Pharmacy Tied to Meningitis Outbreak Declares Bankruptcy

The CBS Evening News reported “The specialty pharmacy linked to that deadly meningitis outbreak filed for chapter 11 bankruptcy protection today.” NBC Nightly News (12/22, story 7, 0:25, Holt, 7.86M) added that the Framingham, Massachusetts-based specialty pharmacy “is facing 130 lawsuits.” According to Reuters, the NECC, in documents filed Friday with the US Bankruptcy Court for […]

FDA Advisory Panel Recommends New Restrictions on Hydrocodone Products

This is a follow-up to an earlier post. An FDA advisory panel’s recommendation regarding hydrocodone restrictions received a substantial amount of coverage in print, online, and on two of last night’s national news broadcasts. Some sources pointed out that the FDA was likely to adopt the recommendation. Additionally, many sources pointed out that the recommendation […]

FDA Panel Hearing to Consider Reclassifying Hydrocodone Drug Products

The Milwaukee Journal Sentinel reports that the Drug Enforcement Administration “has again asked the FDA to consider tightening prescribing and other rules on hydrocodone drugs.” The FDA will hold hearings on Jan. 24 and Jan. 25 to consider whether to move hydrocodone products from schedule III to the highly regulated “schedule II” class under which narcotics such […]

Documents Detail Lax Oversight in Meningitis Outbreak

The New York Times reported, “Newly released documents add vivid detail to the emerging portrait of the Food and Drug Administration’s ineffective and halting efforts to regulate a Massachusetts company implicated in a national meningitis outbreak that has sickened nearly 500 people and killed 34.” In documents, released on Nov. 20, “in response to a Freedom of […]